Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 70518-0886

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 70518-0886). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 01)

Chemical structure of Tramadol Hydrochloride showing its molecular arrangement with a methoxy phenyl group, cyclohexanol ring, and an amine side chain.*

FDA Label Image

Image-2 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 02)

A line graph depicting tramadol concentration (ng/mL) in blood over 24 hours. It compares Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily (solid circles) versus Tramadol Hydrochloride Tablets 50 mg every 6 hours (open circles), showing time in hours on the x-axis and concentration on the y-axis.*

FDA Label Image

Image-3 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 03)

A line graph comparing M1 concentration (ng/mL) over time (hours) between Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol Hydrochloride Tablets 50 mg every 6 hours. The x-axis shows time up to 24 hours, and the y-axis shows M1 concentration ranging from 0 to 120 ng/mL. Two lines represent the two formulations, demonstrating their concentration profiles across the time period.*

FDA Label Image

Image-4 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 04)

A line graph showing the percent of patients achieving response across various response thresholds (percent improvement from baseline) in a study of Tramadol Hydrochloride Extended-Release Tablets. The graph compares four dosage strengths (100 mg, 200 mg, 300 mg, 400 mg) and placebo, with percent response on the vertical axis and response threshold on the horizontal axis.*

FDA Label Image

Image-5 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 05)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 015 Arthritis Pain Intensity VAS Responder Analysis Patients Achieving Various Levels of Response Threshold.' It depicts the percent of patients achieving response on the vertical axis versus response threshold (percent improvement from baseline) on the horizontal axis. Two lines show the comparison between Tramadol Hydrochloride Extended-Release Tablets and Placebo across response thresholds from 0 to 100 percent.*

FDA Label Image

Image (86731d11 21c5 43e2 A5df B96262c9ba5c 408 1)

TRAMADOL HYDROCHLORIDE 200 mg extended release tablet packaging label. The label displays the tablet count as 1 and shows REMEDYREPACK INC. as the labeler. The design includes a green and white color scheme with a distinctive starburst pattern near the bottom.*

FDA Label Image

Image (86731d11 21c5 43e2 A5df B96262c9ba5c 393 1)

TRAMADOL HYDROCHLORIDE 200 mg extended-release oral tablets from REMEDYREPACK INC. The packaging features a white background with a blue flower-like logo composed of several differently sized blue petals clustered in the center. The label shows the product name and strength prominently, along with dosage form and labeler information.*

FDA Label Image

Mm1 (Tramadol HCl 200mg 70518 0886 00)

Label for TRAMADOL HYDROCHLORIDE extended-release 200 mg tablets, oral use, with a quantity of 30 tablets. The label shows the drug as schedule C-IV, intended for prescription use only, and includes the NDC number 70518-0886-00. It also mentions repackaging by RemedyRepack Inc. and manufacturing by Lupin Pharma.*

FDA Label Image

Mm2 (Tramadol HCl 200mg 70518 0886 01)

Label for TRAMADOL HYDROCHLORIDE extended-release 200 mg oral tablets by RemedyRepack Inc. The label shows 30 tablets, designated as Schedule C-IV. It includes the NDC 70518-0886-01, manufacturer Lupin Pharma Baltimore MD, storage instructions, and directions to see package insert.*

FDA Label Image

Mm3 (Tramadol HCl 200mg 70518 0886 02)

Label for TRAMADOL HYDROCHLORIDE extended-release 200 mg tablets, quantity 90, classified as C-IV. The label shows the product as oral extended-release tablets with a highlighted strength of 200 mg. It includes the NDC number 70518-0886-02 and states repackaging by RemedyRepack Inc. Manufacturer Lupin Pharma is listed with address Baltimore, MD. Warning to keep medication out of reach of children and directions to see package insert are present.*

FDA Label Image

Mm4 (Tramadol HCl 200mg 70518 0886 03)

Label for TRAMADOL HYDROCHLORIDE 200 mg extended-release oral tablets, packaged in a quantity of 60. The label indicates the product is a Schedule IV controlled substance and repackaged by RemedyRepack Inc. Information includes NDC number 70518-0886-03, source manufacturer Lupin Pharma in Baltimore, MD, and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.